This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Assessment and workup for delirium

Authoring team

  • the most important step in evaluating suspected delirium is obtaining a collateral history from someone who knows the patient well (for example family member or caregiver) and performing a structured clinical and cognitive assessment (1,3)
  • collateral history is essential to establish baseline cognitive and functional status, confirm acute onset (hours to days), identify symptom fluctuation, and search for potential precipitants (1,3)
  • acute changes in behaviour or alertness should be treated as a clinical vital sign prompting urgent investigation for underlying causes (3)
  • caregivers may identify subtle "soft signs" prior to overt delirium (for example changes in diet, fluid intake, mobility, circadian rhythm, or mood), which require a high index of clinical suspicion (3)

Cognitive and Delirium Screening Tools

  • structured brief validated screening tools are recommended across clinical settings (including community and Hospital at Home) (3):
    • SQiD (Single Question in Delirium): asking an informant "Do you think [name] has been more confused lately?" (sensitivity 80%, specificity 71%) (3)
    • 4AT (4 "A"s Test): rapid assessment (<2 minutes) evaluating alertness, AMT4, attention, and acute change/fluctuating course (sensitivity 88%, specificity 88%) (3)
    • CAM (Confusion Assessment Method): standard 4-feature algorithm assessing acute onset/fluctuation, inattention, disorganised thinking, and altered level of consciousness (sensitivity 94%, specificity 89%) (1,3)
  • alternative brief cognitive/attention tasks if time constrained:
  • naming days of the week or months of the year backwards (1)
  • serial sevens subtraction or digit span recitation backwards (1)
  • baseline cognitive screening tools (for example IQCODE) help identify underlying pre-existing cognitive impairment (3)

Physical and Neurological Examination

  • vital signs: record pulse, temperature, blood pressure, respiratory rate, and oxygen saturations to identify infection or physiological disturbance (for example hypoxia) (3)
  • focused clinical examination: evaluate cardiovascular, respiratory, and abdominal systems (3)
  • pain assessment: evaluate both self-reported pain and non-verbal pain signs (for example grimacing or wincing during examination) (1,3)
  • search for precipitants: assess for constipation, urinary retention (for example bladder scan), dehydration, fluid overload, occult injuries, and pressure areas/wounds for infection (1,3)
  • sensory impairments: check for vision or hearing loss, ensuring glasses and hearing aids are present and functional (1,3)
  • neurological assessment: search for focal neurological signs, visual field changes, speech/swallowing disturbances, or meningeal signs (1,3)

Targeted Investigations

  • bedside tests:
    • blood glucose and blood ketones (to identify hypoglycaemia, hyperglycaemia, or ketoacidosis) (1,3)
    • bladder scan (to exclude urinary retention) (3)
    • electrocardiogram (ECG) (to evaluate cardiac ischaemia or arrhythmias) (3)
    • urine analysis (for haematuria/proteinuria in acute kidney injury, glycosuria, or suspected UTI in non-catheterised adults aged under 65 years; routine dipstick testing is avoided in older care home residents due to high rates of asymptomatic bacteriuria) (3)
  • initial laboratory tests:
    • full blood count (anaemia or infection), urea and electrolytes (renal failure, hyponatraemia, or uraemia), liver function tests, serum calcium (hypercalcaemia), and C-reactive protein (inflammatory/infective response) (3)
    • microbiological and virological sampling (blood cultures, wound swabs, sputum, viral respiratory panels [COVID-19, influenza, RSV], or stool testing) when infection is suspected (3)
    • investigation of reversible cognitive decline triggers when underlying dementia is suspected (for example thyroid function, HbA1c, folate, and vitamin B12) (3)
    • selective tests: drug levels (for example digoxin), troponin, lactate, procalcitonin, or creatine kinase (following a "long lie") (3)
  • imaging tests:
    • point-of-care ultrasound (POCUS) in community/home settings where available (to evaluate consolidation, pleural effusion, ascites, hydronephrosis, or deep vein thrombosis) (3)
    • chest X-ray (if POCUS unavailable and infection or fluid overload suspected) (3)
    • head CT: indicated for new focal neurological signs, reduced consciousness not explained by another cause, recent head injury or falls, anticoagulation therapy, or non-resolving cases of delirium without an identified cause (3)

Reference:

  1. Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014;383(9920):911-922.
  2. NICE. Delirium: prevention, diagnosis and management in hospital and long-term care. Clinical guideline CG103. Published July 2010, last updated January 2023.
  3. Burton JK, Barron K, McGlen S, Jewson H, George P, Lasserson D. Community management of delirium. BMJ. 2026;395:e100817.

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page